The TB Alliance and its partners will be presenting recent advances in TB research and development at the ICAAC 2011 conference. Posters and presentations will detail results from the first-ever clinical trial of a novel TB regimen, pre-clinical research identifying promising future regimens, and progress on the development of an exciting new class of anti-TB compounds.
A full schedule of TB Alliance presentations is below. Biographies and pictures of presenters can be viewed by clicking on their names.
4th Int’l Workshop on Clinical Pharmacology of TB Drugs
Combination therapy with novel TB drugs
16th September 2011
11:30 AM -12:00 PM
Workshop presentation
Khisi Mduli
Hotel Congress Plaza
Novel TMC207-containing regimens have sterilizing activity in murine tuberculosis
16th September 2011
Workshop presentation
Eric Nuermberger
Hotel Congress Plaza
EBA, Theoretical aspects and practical experience
16th September 2011
4:15 – 4:30 PM
Workshop presentation
Andreas Diacon
Hotel Congress Plaza
ICAAC 2011
SAR of Riminophenazine Class and Discovery of New Anti-tuberculosis Agents Active against Multidrug-Resistant Tuberculosis
17th September 2011
12:30 – 1:30 PM
Topical Poster Walk presentation
Chris Cooper
Exhibit Hall F1
Development of riminophenazines for the treatment of tuberculosis
17th September 2011
1:45 – 3:45 PM
Poster Summary Session on novel antimicrobial agents and strategies
Anna Upton
Room W375c
Pyrazinamide Increases the Early Bactericidal Activity of TMC207 and PA-824 in Patients with Newly Diagnosed, Smear-positive Pulmonary Tuberculosis
18th September 2011
11:15 AM
Poster (P-931a)
Andreas Diacon
Exhibit Hall F1
Phase 2 Trial of a Novel 3-Drug Regimen for Both MDR and Drug Sensitive (DS) TB
18th September 2011
11:15 AM
Poster (P-931b)
Andreas Diacon
Exhibit Hall F1
SAR of Riminophenazine Class and Discovery of New Anti-tuberculosis Agents Active against Multidrug-Resistant Tuberculosis
19th September 2011P.M.
11:15 AM -1:15 PM
Poster (F1-1358)
Chris Cooper
Exhibit Hall F1
Clofazimine Analogs with Superior Efficacy against Experimental Tuberculosis and Reduced Potential for Tissue Discoloration
19th September 2011
11:15 AM -1:15 PM
Poster (F1-1359)
Zhenkun Ma
Exhibit Hall F1
Anti-tubercular Clofazimine Analogs that Demonstrate a Range of Tissue Distribution Patterns Following Eight Weeks of Dosing to mice
19th September 2011
11:15 AM – 1:15 PM
Poster (F1-1360)
Anna Upton
Exhibit Hall F1
Novel TMC207-containing Regimens Have Sterilizing Activity In Murine Tuberculosis
19th September 2011
11:15 AM
Poster (B-1205)
Eric Nuermberger
Exhibit Hall F1